New England Journal of Medicine publishes COVID-19 treatment trial results

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news